Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Effect of biological therapy on work participation in patients with ankylosing spondylitis: a systematic review.

van der Burg LR, Ter Wee MM, Boonen A.

Ann Rheum Dis. 2012 Dec;71(12):1924-33. doi: 10.1136/annrheumdis-2012-201914. Epub 2012 Sep 6. Review.

PMID:
22956595
[PubMed - indexed for MEDLINE]
2.

The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review.

ter Wee MM, Lems WF, Usan H, Gulpen A, Boonen A.

Ann Rheum Dis. 2012 Feb;71(2):161-71. doi: 10.1136/ard.2011.154583. Epub 2011 Oct 13. Review.

PMID:
21998122
[PubMed - indexed for MEDLINE]
3.

Indirect comparison of the effects of anti-TNF biological agents in patients with ankylosing spondylitis by means of a mixed treatment comparison performed on efficacy data from published randomised, controlled trials.

Migliore A, Broccoli S, Bizzi E, Laganà B.

J Med Econ. 2012;15(3):473-80. doi: 10.3111/13696998.2012.660255. Epub 2012 Feb 16. Review.

PMID:
22335398
[PubMed - indexed for MEDLINE]
4.

Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial.

van der Heijde D, Han C, DeVlam K, Burmester G, van den Bosch F, Williamson P, Bala M, Han J, Braun J.

Arthritis Rheum. 2006 Aug 15;55(4):569-74.

PMID:
16874778
[PubMed - indexed for MEDLINE]
Free Article
5.

[The role of biologic agents in the therapy of ankylosing spondylitis].

Géher P, Nagy MB, Péntek M, Tóth E, Brodszky V, Gulácsi L.

Orv Hetil. 2006 Jul 2;147(26):1203-13. Review. Hungarian.

PMID:
16898082
[PubMed - indexed for MEDLINE]
6.

Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials.

Fouque-Aubert A, Jette-Paulin L, Combescure C, Basch A, Tebib J, Gossec L.

Ann Rheum Dis. 2010 Oct;69(10):1756-61. doi: 10.1136/ard.2008.098822. Epub 2009 Jul 28. Review. Erratum in: Ann Rheum Dis. 2012 Aug;71(8):1434.

PMID:
19640854
[PubMed - indexed for MEDLINE]
7.

Biologic therapies in the spondyloarthritis: new opportunities, new challenges.

Braun J, Brandt J, Listing J, Rudwaleit M, Sieper J.

Curr Opin Rheumatol. 2003 Jul;15(4):394-407. Review.

PMID:
12819466
[PubMed - indexed for MEDLINE]
8.

Etanercept and efalizumab for the treatment of psoriasis: a systematic review.

Woolacott N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Vergel YB, Misso K, Light K, Chalmers R, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Nov;10(46):1-233, i-iv. Review.

PMID:
17083854
[PubMed - indexed for MEDLINE]
Free Article
9.

The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.

Barkham N, Kong KO, Tennant A, Fraser A, Hensor E, Keenan AM, Emery P.

Rheumatology (Oxford). 2005 Oct;44(10):1277-81. Epub 2005 Aug 16.

PMID:
16105913
[PubMed - indexed for MEDLINE]
Free Article
10.

Etanercept: new indication. For ankylosing spondylitis: another option.

[No authors listed]

Prescrire Int. 2005 Jun;14(77):92-3.

PMID:
15981387
[PubMed - indexed for MEDLINE]
11.

Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly.

Braun J, McHugh N, Singh A, Wajdula JS, Sato R.

Rheumatology (Oxford). 2007 Jun;46(6):999-1004. Epub 2007 Mar 27.

PMID:
17389658
[PubMed - indexed for MEDLINE]
Free Article
12.

Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis.

Boonen A, van der Heijde D, Severens JL, Boendermaker A, Landewé R, Braun J, Brandt J, Sieper J, van der Linden S.

Ann Rheum Dis. 2006 Feb;65(2):201-8. Epub 2005 Jul 13.

PMID:
16014677
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept.

Braun J, Baraliakos X, Listing J, Sieper J.

Arthritis Rheum. 2005 Aug;52(8):2447-51. Review.

PMID:
16052578
[PubMed - indexed for MEDLINE]
Free Article
14.

Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review.

Boonen A, de Vet H, van der Heijde D, van der Linden S.

J Rheumatol. 2001 May;28(5):1056-62. Review.

PMID:
11361189
[PubMed - indexed for MEDLINE]
15.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

PMID:
16948890
[PubMed - indexed for MEDLINE]
Free Article
16.

Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.

Maksymowych WP, Poole AR, Hiebert L, Webb A, Ionescu M, Lobanok T, King L, Davis JC Jr.

J Rheumatol. 2005 Oct;32(10):1911-7.

PMID:
16206346
[PubMed - indexed for MEDLINE]
17.

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab.

Baraliakos X, Listing J, Rudwaleit M, Brandt J, Sieper J, Braun J.

Ann Rheum Dis. 2005 Oct;64(10):1462-6. Epub 2005 Mar 18.

PMID:
15778240
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Infliximab: in ankylosing spondylitis.

Robinson DM, Keating GM.

Drugs. 2005;65(9):1283-91; discussion 1292-4. Review.

PMID:
15916451
[PubMed - indexed for MEDLINE]
19.

Maintained clinical response of infliximab treatment in ankylosing spondylitis: a 6-year long-term study.

Saougou I, Markatseli TE, Voulgari PV, Drosos AA.

Joint Bone Spine. 2010 Jul;77(4):325-9. doi: 10.1016/j.jbspin.2010.02.014. Epub 2010 May 8.

PMID:
20452801
[PubMed - indexed for MEDLINE]
20.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

PMID:
18088161
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk